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therewith is price elastic. We estimate that approximately 40% of the increase in pre-
scription volume results from REGO. Additionally to the increase in expenditures the 
sickness funds are facing a loss of income as less co-payment rates are paid. Prescrip-
tions with prices lower than the co-payment rate are not paid by the insured anymore, 
but by the sickness funds. These low-price prescriptions cause a dramatic increase in 
volume, however, not a decisive increase in total expenditures. CONCLUSIONS: The 
time courses allow us to evaluate the effects of REGO. Furthermore they reveal 
information about the behaviour of the demand function, when the price drops to 
zero. The intention of REGO is to improve equity by protecting poorer and heavy 
users of prescription drugs from the ﬁnancial burden of co-payments. Demand 
increases, when REGO reduces the price for prescription drugs to a 0. This could 
indicate an improvement in equity and access, however, affects on efﬁciency have to 
be shown in further analysis.
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OBJECTIVES: The distribution of free samples to patients in the US, the retail value 
of which is US$20 billion annually, is controversial. Proponents assert that free 
samples improve medication access for low-income patients while opponents argue 
free sample availability drives the choice of expensive, brand-name pharmaceuticals. 
It is critical to shed light on the beneﬁts and costs of free samples for older adults, in 
particular, given their high drug cost burden. Our objective was to determine the 
proportion of older adults receiving free samples, and to examine the association 
between free sample receipt and communication with physicians and cost-related 
non-adherence to medicines. METHODS: In 2006, we conducted a national telephone 
survey of persons age 65 and older in the U.S., over-sampling those with low-incomes. 
The survey included several questions related to prescription drug insurance coverage, 
medication use and doctor-patient communication. RESULTS: Half of older adults 
surveyed had received free samples from their doctors at least once in the past 12 
months, with 21% receiving samples more than once. Two thirds of seniors who had 
talked to their doctor about the cost of medicines they are taking received free samples 
compared to 43% of those who did not have such discussions. Seniors who received 
free samples were less likely to agree there is nothing their doctor can do to help lower 
drug costs (40% vs. 47%) than those who did not receive samples. Free sample receipt 
was associated with a lower risk of cost-related non-adherence (failing to ﬁll prescrip-
tions, skipping or reducing doses due to cost) (31% vs. 26%). CONCLUSIONS: 
Receipt of free samples is common among older adults and appears to increase with 
discussions of drug costs between doctors and patients. Free sample receipt may help 
reduce cost-related non-adherence, however, further study is needed to shed light on 
these behaviors.
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OBJECTIVES: Our aim was to estimate the hospitalization length of stay (LOS) and 
risk of death within hospitalization, associated with the occurrence of post-operative 
residual curarization (PORC) and adverse events (AE) possibly or probably related 
to neuromuscular blockade reversal agents (NMBRA) use. METHODS: Data was 
obtained from hospitalizations occurring in Portuguese public hospitals in 2007. Surgi-
cal procedures from (ICD-9-CM CSP codes): central nervous (01–05), endocrine 
(06–07), respiratory (30–34), cardiovascular (35–39), hematologic and lymphatic 
(40–41) and digestive (42–54) systems were selected due to their high potential for 
NMBRA use. According to clinical expertise and ICD-9 diagnosis classiﬁcation, AE 
and events PORC were grouped into the following outcomes: bronchospasm, dyspha-
gia or dyspepsia, cardiac dysrhythmias, tachycardia, hypertension, hypotension, xero-
stomia, nausea, vomiting or abdominal pain, central nervous system complications 
and allergic, psychological, respiratory, sensation and visual disturbances. Data con-
sisted of admission and discharge date, age, gender, primary and secondary diagnosis, 
primary and secondary surgical procedures. No data was available regarding the type 
of NMBRA used. Within hospital, risk of death was estimated with parametric sur-
vival (Weibull) regression models. LOS was estimated through negative binomial 
regression models. RESULTS: The analysis included 136,150 surgical procedures 
(55.0% female and mean(SD) age 54.2(18.9) years). Rates of AE and PORC were 
25.5% and 3.0%, respectively. Crude death rate was 2.8%. The risk of death was 1.3 
(95%CI: 1.2–1.4) times higher in patients with AE and 2.0 (95%CI: 1.9–2.2) times 
higher in patients with PORC, adjusted for other covariates. The mean LOS was 5.3 
days (30 days, n  130,254). LOS was signiﬁcantly increased both in patients with 
at least one AE (2.2 days, 95%CI: 2.1–2.4) or at least one PORC event (7.4 days, 
95%CI: 6.7–8.2). CONCLUSIONS: Post-operative residual curarization and adverse 
events possibly or probably related to neuromuscular blockade reversal agents use are 
associated with increased inpatient death and extended hospital length of stay.
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OBJECTIVES: The occupancy rate is a calculation to show the actual utilization of 
the inpatient health facility for a period. It is expressed as a percent. Our aim was to 
deﬁne occupancy rates between 2000 and 2008 in the Middle-European country, 
Hungary. Health care of its 10 million inhabitants was “secured” by 59.584 beds until 
31st March 2007 and by 43.943 beds afterwards. METHODS: To calculate the 
average occupancy rate for a typical one-year reporting period, two data items are 
needed. The “Inpatient Days of Care” and the “Bed Days Available”. Data were got 
from the National Health Insurance Fund Administration. To calculate occupancy 
rate the (Inpatient Days of Care / Bed Days Available) x 100 formula was used. 
RESULTS: The highest occupancy rate between 2000–2008 in Hungary was 76.3% 
in 2001. From that time the occupancy rate continuously decreased independently of 
the decrease of beds available. The ﬁgure reached 66.9% in 2007. In 2008 a slight 
increase could be seen (70.7%), which seemed not to be signiﬁcant, but in comparison 
to the decrease of beds (26%) at spring of 2007. Examining the gathered monthly 
data, it was realized that in February bed occupancy was the highest, 77.2%. Examin-
ing occupancy rate for calendar days, it got the highest ﬁgure on Thursday, 77%. In 
order to deﬁne how many beds are really needed, it has to be examined occupancy 
rate on every single calendar day. Evaluating the data it was observed that there were 
days when occupancy rate was higher than 91% but regularly reached 80%. CON-
CLUSIONS: On the basis of the above mentioned it can be proved that planning bed 
number, in addition to yearly average, the daily occupancy rate has to be considered, 
as stress on health care is highly ﬂuctuating due to unplanned, sudden cases.
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OBJECTIVES: Cost calculations show the importance of the utilisation of the capac-
ity. The aim of the study is to analyse the percentage of bed occupancy in the intensive 
care units in Hungary according to the Diagnosis related Groups (DRG) system. 
METHODS: Data were derived from the National Health Insurance Fund Administra-
tion (NHI). The bed occupancy rate of the ﬁrst eleven months of the year 2008 were 
analysed and compared to the mean of the Hungarian rate and to the means of two 
other recognized specialties. RESULTS: The number of beds was not ﬂuctuated 
throughout the examined eleven months. The bed capacity of the Hungarian hospitals 
was 48.6 beds per 10,000 people. 2.82% of the total hospitals beds, 1.37 beds per 
10,000 people, were in intensive care units. The departments of internal medicine had 
14.54% and the departments of surgery had 10.95% share in the Hungarian hospital 
beds. The percentage of occupancy of the intensive care units was 58.2%, of the 
departments of internal medicine was 75.63% and of the departments of surgery was 
65.29%. The total Hungarian hospitals occupancy ratio was 69.84%, more than 10% 
higher compared to the intensive units. CONCLUSIONS: Without the variable costs 
of the treatments, the outlay of an intensive care unit is remarkable. A better occu-
pancy of the intensive care units can increase the reimbursement for the hospitals or 
the decreases in the number of inpatient beds can be a cost-reduction strategy in the 
Hungarian Diagnosis-related Groups (DRG) ﬁnancing system.
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OBJECTIVES: The management of the large patient population chronically treated 
with oral anticoagulation therapy (OAT) poses organisational challenges that in Italy 
are traditionally approached with centralised procedures, relying on hospital-based 
clinics. However, the availability of near-patient testing devices for the monitoring of 
OAT effectiveness (INR measurement) allows for alternative or complementary man-
agement models (patient self-monitoring—PSM). PSM has been proven effective and 
safe, and could be attractive, especially in the perspective of the patient, whose life 
could be severely affected by the costs and times implied in the process of the OAT 
management. In order to assess PSM potential economic impact in Italy, there is a 
need for real-world economic and organisational data. This study was planned to 
investigate treatment patterns and to estimate the average costs borne by OAT patients 
in Italy. METHODS: A 19-item questionnaire, investigating the characteristics of the 
patient, his/her therapeutic regimens, the structures involved and the distances from 
home, the frequencies and the amount of time implied in the management of the OAT, 
